Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developmental origins and oncogenic pathways in malignant brain tumors
Q. Richard Lu, Lily Qian, Xianyao Zhou
Wiley Interdisciplinary Reviews Developmental Biology (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
Dandan Li, Lingyun Xia, Pan Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 78
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Liguo Zhang, Xuelian He, Xuezhao Liu, et al.
Cancer Cell (2019) Vol. 36, Iss. 3, pp. 302-318.e7
Open Access | Times Cited: 121
Dual and multi-targeted nanoparticles for site-specific brain drug delivery
Yan Luo, Hang Yang, Yifan Zhou, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 195-215
Closed Access | Times Cited: 96
Histone Modifications and their Role in Epigenetics of Cancer
Sumera Zaib, Nehal Rana, Imtiaz Khan
Current Medicinal Chemistry (2021) Vol. 29, Iss. 14, pp. 2399-2411
Closed Access | Times Cited: 74
Single-Cell Transcriptomics Revealed Subtype-Specific Tumor Immune Microenvironments in Human Glioblastomas
Yong Xiao, Zhen Wang, Mengjie Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression
Haiyang Xu, Guifang Zhao, Yu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 69
Quantum dots: The cutting-edge nanotheranostics in brain cancer management
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 698-715
Closed Access | Times Cited: 36
Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
Roberta Azzarelli
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 46
Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 24
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
Aleeha Noon, Stefanie Galbán
Neoplasia (2023) Vol. 40, pp. 100899-100899
Open Access | Times Cited: 15
Growth of the prefrontal cortical glioblastoma altered cognitive and emotional behaviors via mediating miRNAs and GABA-A receptor signaling pathways in rats
Sepide Nateghi, Ameneh Rezayof, Fatemeh Kouhkan, et al.
Brain Research Bulletin (2025), pp. 111227-111227
Open Access
The Potential of Pharmacological Intervention Targeting NEDD4 in Glioma
Amjad Z. Alrosan, Enaam Al Momany, Ghaith B. Heilat, et al.
Heliyon (2025), pp. e42996-e42996
Open Access
Missense genetic variant in IQCA1 gene in patients with meningioma
Sepideh Jahangiri, Zahra Abdan, Mehdi Totonchi, et al.
Acta Neurologica Belgica (2025)
Closed Access
Engineered hydrogels for brain tumor culture and therapy
Jai Thakor, Samad Ahadian, A. Niakan, et al.
Bio-Design and Manufacturing (2020) Vol. 3, Iss. 3, pp. 203-226
Open Access | Times Cited: 38
SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis
Yaxuan Zhang, Yin Zhang, Sen Wang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2299-2310
Open Access | Times Cited: 29
Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids
Roberta Azzarelli, Michela Ori, Anna Philpott, et al.
Biology Open (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 28
Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas
Nihar Kathrani, Richa Singh Chauhan, Abhishek Kotwal, et al.
Neuroradiology (2022) Vol. 64, Iss. 8, pp. 1519-1528
Closed Access | Times Cited: 17
Targeting the epigenome of cancer stem cells in pediatric nervous system tumors
Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2241-2255
Closed Access | Times Cited: 10
The Spectrum of Molecular Pathways in Gliomas—An Up-to-Date Review
Reinhold Nafe, Elke Hattingen
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2281-2281
Open Access | Times Cited: 10
A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know
Pedro David Delgado‐López, Patricia Saiz-Lopez, Ricardo Gargini, et al.
Clinical & Translational Oncology (2020) Vol. 22, Iss. 11, pp. 1909-1922
Closed Access | Times Cited: 24
Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance
Maria D’Amico, Francesca De Amicis
Cancer Drug Resistance (2022) Vol. 5, pp. 939-53
Open Access | Times Cited: 15
Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss–Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities
Ravinder Verma, Xiameng Chen, Dazhuan Xin, et al.
Cancer Research (2023) Vol. 83, Iss. 6, pp. 890-905
Open Access | Times Cited: 8
Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives
Xiande Wang, Cheng Wu, Shiming Liu, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1370-1383
Open Access | Times Cited: 13
Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation
Anna Danielsson, Kristell Barreau, Teresia Kling, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top